Manik joined Polaris in 2021 and serves as a senior associate in the Boston office. He is primarily focused on early-stage biotech with a focus in immunology, oncology, neuroscience and machine learning therapeutic platforms.
Prior to joining Polaris, Manik worked in clinical development at Biohaven Pharmaceuticals, helping develop their glutamate platform compounds in rare ataxias. Before Biohaven, Manik worked at Potenza Therapeutics in business development and at Merck & Co. in their Computational Genomics research group.
Manik received his MD and PhD from Yale School of Medicine where he developed novel machine learning algorithms for different genomics applications in immunology, oncology and neuroscience. Manik completed his undergraduate studies at Harvard College.
While working at Polaris, Manik is concurrently completing his residency in Internal Medicine at Massachusetts General Hospital.